Ajanta Pharma Launches Acid Reflux Drug In US

New Delhi: Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers, in the American market after receiving final approval from the US Food and Drug Administration (FDA).

The company has launched the product in the US through its wholly-owned subsidiary - Ajanta Pharma USA Inc, Ajanta Pharma said in a filing to the BSE.

The approval from the US health regulator (FDA) is for the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg, it added.

The capsules are a generic version of Santarus Inc's Zegerid capsules.

The company has 26 abbreviated new drug applications (ANDAs), of which it has received final approvals for 11 and tentative nods for one, while 14 are under review with the US regulator, it added.

At 3:09 p.m., shares in Ajanta Pharma were trading 0.6 per cent lower at Rs 1,588.45 apiece on the BSE, whose benchmark Sensex index was down 0.13 per cent.